Shopping Cart
- Remove All
- Your shopping cart is currently empty
Aducanumab (BIIB037), A selective human immunoglobulin gamma-1 (IgG1) monoclonal antibody, targets the clustered form of amyloid beta (Aβ). Aducanumab shows brain permeability and may be used to treat Alzheimer's disease (AD).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $189 | In Stock | |
5 mg | $478 | In Stock | |
10 mg | $813 | In Stock |
Description | Aducanumab (BIIB037), A selective human immunoglobulin gamma-1 (IgG1) monoclonal antibody, targets the clustered form of amyloid beta (Aβ). Aducanumab shows brain permeability and may be used to treat Alzheimer's disease (AD). |
Alias | BIIB037 |
Molecular Weight | 145.93 kDa |
Cas No. | 1384260-65-4 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.